New CEO and Medical Director
Dr. Hjalgrim comes with a long clinical career from the public healthcare sector and since 2007 Dr. Hjalgrim has been senior consultant at the Danish Epilepsy Centre, Filadelfia. Dr. Hjalgrim established and was head of the Epilepsy Research Unit at Filadelfia, and for the past four years she has been Medical Director at the Danish Epilepsy Centre.Amplexa Genetics A/S is a well-established molecular genetic test facility, providing clinical data analysis and interpretation to the healthcare sector as well as partaking in international research projects.
For the last six years Amplexa Genetics has developed and established efficient technical and analytical platforms for next generation genetic analysis. By adding the new CEO and Medical Director, Amplexa Genetics strengthens its management team and sharpens the clinical profile. This is a natural next-step in the development of the company and it is a progression further into precision medicine and clinical genetics.